SlideShare a Scribd company logo
1 of 39
Pharmacokinetics
2
Distribution
The delivery of a drug from the plasma to the
interstitium primarily depends on
• Blood flow
• Capillary permeability
• The degree of binding of the drug to plasma
and tissue proteins and
• The relative hydrophobicity of the drug.
Drug distribution is the process by which
a drug reversibly leaves the bloodstream
and enters the interstitium (extracellular
fluid)
and/or the cells of the tissues.
A. Blood flow
The rate of blood flow to the
tissue capillaries varies widely
as a result of the unequal distribution
of cardiac output to the various organs.
Blood flow to the brain, liver,
and kidney is greater than that to the
skeletal muscles;
adipose tissue has a still lower rate of blood flow.
This differential blood flow partly explains
the short duration of hypnosis produced by
a bolus IV injection of thiopental.
The high blood flow, together with
the superior lipid solubility of thiopental,
permit it to rapidly move into the CNS
and produce anesthesia.
Slower distribution to skeletal muscle
and adipose tissue lowers the plasma concentration
sufficiently
so that the higher concentrations
within the CNS decrease,
and consciousness is regained
B. Capillary permeability
Capillary permeability is determined
by capillary structure
and
by the chemical nature of the drug
1. Capillary structure:
Capillary structure varies widely
in terms of the fraction of the basement membrane
that is exposed by slit junctions between endothelial cells
cells
In the brain, the capillary structure is continuous,
and there are no slit junctions.
This contrasts with the liver and spleen,
where a large part of the basement membrane
is exposed due to large, discontinuous capillaries
through which large plasma proteins can pass.
Blood-brain barrier:
To enter the brain, drugs must pass through the
endothelial cells of the capillaries of
the CNS or be actively transported.
For example,
a specific transporter for the levodopa in the brain
By contrast, lipid-soluble drugs
readily penetrate into the CNS
because they can dissolve in the membrane
of the endothelial cells
Ionized or polar drugs
generally fail to enter the CNS because
they are unable to pass through the endothelial cells
of the CNS, which have no slit junctions
2. Drug structure:
The chemical nature of a drug strongly influences its
ability to cross cell membranes.
Hydrophobic drugs,
which have a uniform distribution of electrons
and no net charge,
readily move across most biologic membranes.
These drugs can dissolve in
the lipid membranes and, therefore,
permeate the entire cell's surface.
The major factor influencing
the hydrophobic drug's distribution is
the blood flow to the area
By contrast, hydrophilic drugs, which have either a
non-uniform distribution of electrons
or a positive or negative charge,
do not readily penetrate cell membranes,
and therefore,
must go through the slit junctions
C. Binding of drugs to plasma proteins
Reversible binding to plasma proteins
sequesters drugs in a non diffusible form
and slows their transfer out of the
vascular compartment
Binding is relatively nonselective
as to chemical structure and
takes place at sites on the protein
to which endogenous compounds, such as bilirubin, normally
normally attach
Plasma albumin is the major
drug-binding protein and
may act as a drug reservoir;
that is, as the concentration of the free drug
decreases
due to elimination by metabolism or excretion,
the bound drug dissociates from the protein.
This maintains the free-drug
concentration as a constant fraction
of the total drug in the plasma.
Volume of Distribution
The volume of distribution is
a hypothetical volume of fluid
into which a drug is dispersed.
Although the volume of distribution has
no physiologic or physical basis,
it is sometimes useful
to compare the distribution of a drug with the
volumes of the water compartments in the body
A. Water compartments in the body
Once a drug enters the body,
from whatever route of administration,
it has the potential to distribute
into any one of
three functionally distinct compartments
of body water or
to become sequestered in a cellular site.
1. Plasma compartment:
If a drug has a very large molecular weight
or binds extensively to plasma proteins,
it is too large to move out
through the endothelial slit junctions of the capillaries
and, thus,
is effectively trapped within the plasma compartment.
As a consequence,
the drug distributes
in a volume (the plasma) that is about
six percent of the body weight or,
in a 70-kg individual, about 4 L of body fluid.
Heparin shows this type of distribution.
2. Extracellular fluid:
If a drug has a low molecular weight
but is hydrophilic,
it can move through the endothelial
slit junctions of the capillaries
into the interstitial fluid.
However, hydrophilic drugs
cannot move across the lipid membranes
of cells to enter the water phase inside the cell.
Therefore, these drugs distribute into a
volume that is the sum of the plasma water and
the interstitial fluid, which together constitute the
extracellular fluid.
This is about twenty percent of the body weight, or
about 14 L in a 70-kg individual.
Aminoglycoside antibiotics show this type of
distribution.
Total body water:
If a drug has a low molecular weight
and is hydrophobic, not only can it
move into the interstitium through the slit junctions,
but it can also move through the cell membranes
into the intracellular fluid.
The drug, therefore, distributes into a volume of
about sixty percent of body weight, or about 42 L
in a
70-kg individual.
Ethanol exhibits this apparent volume of distribution
below).
Other sites:
In pregnancy, the fetus may take up drugs
and thus increase the volume of distribution
Drugs that are extremely lipid-soluble,
such as thiopental,
may also have unusually high volumes of
distribution
Apparent volume of distribution
A drug rarely associates exclusively with only one of the water
the water compartments of the body.
Instead, the vast majority
of drugs distribute into several compartments,
often avidly binding cellular components
for example,
Lipid (abundant in adipocytes and cell membranes), proteins
proteins (abundant in plasma and within cells),
or nucleic acids (abundant in the nuclei of cells)
Therefore, the volume into which drugs distribute
is called the apparent volume of distribution, or Vd.
Another useful way to think of this constant is as
the partition coefficient of a drug between the
plasma and the rest of the body
Determination of Vd
Distribution of drug in the absence of elimination:
The apparent volume into which a drug distributes,
Vd, is determined by
injection of a standard dose of drug,
which is initially contained entirely
in the vascular system.
The agent may then move from the plasma into the
interstitium and into cells,
causing the plasma concentration
to decrease with time
Assume for simplicity that the
drug is not eliminated from the body;
the drug then achieves a uniform
concentration
that is sustained with time
The concentration within the
vascular compartment is
the total amount of drug administered,
divided by the volume into which
it distributes
where C = the plasma concentration of the drug
and
D = the total amount of drug in the body.
For example,
if 25 mg of a drug (D = 25 mg) are administered
and the plasma concentration is 1 mg/L,
then Vd = 25 mg/1 mg/L
= 25 L
Distribution of drug
when elimination is present:
In reality, drugs are eliminated from the body,
and a plot of plasma concentration versus time
shows two phases.
The initial decrease in plasma concentration
is due to a rapid distribution phase
in which the drug is transferred
from the plasma into the interstitium and
the intracellular water
This is followed by a slower elimination phase
during which the drug leaves the plasma
compartment
and is lost from the body
for example, by renal or biliary excretion or by
hepatic biotransformation
The rate at which the drug is
eliminated is usually proportional to the
concentration of drug, C;
that is, the rate for most drugs is
first-order and shows
a linear relationship with time
if ln C (where lnC is the natural log
of C, rather than C) is plotted versus
time.
This is because the elimination
processes are not saturated
Calculation of drug concentration
if distribution is instant:
Assume that the elimination process
began at the time of injection
and continued throughout the distribution phase
Then, the concentration of
drug in the plasma, C,
can be extrapolated back to time zero
(the time of injection) to determine C0,
Which is the concentration of drug that would have
been achieved if the distribution phase had occurred
For example, if 10 mg of drug are injected into a
patient and the plasma concentration is extrapolated
to
time zero,
the concentration is C0 = 1 mg/L
(from the graph shown),
and then Vd = 10 mg/1 mg/L
= 10 L.
Uneven drug distribution
between compartments:
The apparent volume of distribution assumes that the
drug distributes uniformly,
in a single compartment.
However, most drugs distribute unevenly,
in several compartments,
and the volume of distribution
does not describe a real, physical volume,
but rather, reflects the ratio of drug in the extra-
plasmic spaces relative to the plasma space.
Nonetheless, Vd is useful because
It can be used to calculate the amount of drug
needed to achieve a desired plasma concentration.
For example,
assume the arrhythmia of a cardiac patient
is not well controlled due to
inadequate plasma levels of digitalis.
Suppose the concentration of the drug in the plasma
is C1 and the desired level of digitalis
(known from clinical studies) is a higher
concentration, C2.
The clinician needs to know how much additional
drug should be administered to bring the circulating
level of the drug from C1 to C2:
(Vd)(C1) = Amount of drug initially in the body
(Vd)(C2) = Amount of drug in the body needed to
achieve the desire plasma concentration
The difference between the two values is the
additional dosage needed
Effect of a large Vd
on the half-life of a drug
A large Vd has an important influence
on the half-life of a drug,
because drug elimination depends on the
amount of drug delivered to the liver or kidney
(or other organs where metabolism occurs)
per unit of time
Delivery of drug to the organs of elimination
depends not only on blood flow,
but also on the fraction of the drug in the plasma.
If the Vd for a drug is large,
most of the drug is in the extra plasmic space and
is unavailable to the excretory organs.
Therefore, any factor that increases
the volume of distribution can lead to
an increase in the half-life and extend the
duration of action of the drug.
Note: An exceptionally large Vd indicates
considerable sequestration of the drug
in some organ or compartment
O

More Related Content

What's hot (20)

Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Hepatic clearance and elimination
Hepatic clearance and eliminationHepatic clearance and elimination
Hepatic clearance and elimination
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Drug Distribution.ppt
Drug Distribution.pptDrug Distribution.ppt
Drug Distribution.ppt
 
Distribution
DistributionDistribution
Distribution
 
Drug absorption
Drug absorption Drug absorption
Drug absorption
 
05.0 drug distribution
05.0 drug distribution05.0 drug distribution
05.0 drug distribution
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Drug distribution and elimination
Drug distribution and eliminationDrug distribution and elimination
Drug distribution and elimination
 
Drug absorption
Drug absorptionDrug absorption
Drug absorption
 
Umesh
UmeshUmesh
Umesh
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Distribution of drug
Distribution of drugDistribution of drug
Distribution of drug
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 

Similar to Drug Distribution & Factors Affecting Distribution

3. Pharmacokinetics - I.ppt
3. Pharmacokinetics - I.ppt3. Pharmacokinetics - I.ppt
3. Pharmacokinetics - I.pptAreejKhalid28
 
pharmacokinetics of injectable anesthetics  / dental implant courses by India...
pharmacokinetics of injectable anesthetics  / dental implant courses by India...pharmacokinetics of injectable anesthetics  / dental implant courses by India...
pharmacokinetics of injectable anesthetics  / dental implant courses by India...Indian dental academy
 
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptx
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptxPharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptx
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptxMuhammad Kamal Hossain
 
Drug distribution
Drug distribution Drug distribution
Drug distribution Faisal Shah
 
Drug distribution
Drug distribution Drug distribution
Drug distribution Faisal Shah
 
ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy AnuragSingh799
 
drug drugdistribut 1
drug drugdistribut 1drug drugdistribut 1
drug drugdistribut 1AMAL MOHAMMED
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusionDr.saqib habib
 
05.1 drug distribution
05.1 drug distribution05.1 drug distribution
05.1 drug distributionRichardPaul54
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugsDipak Bari
 
Basics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxBasics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxrubinawatangi1
 
Distribution edited
Distribution editedDistribution edited
Distribution editedmizan00
 
Pharamcokinetics: Distribution
Pharamcokinetics: Distribution Pharamcokinetics: Distribution
Pharamcokinetics: Distribution Vijay Kevlani
 
Pharmacokinetics in Anaesthesiology
Pharmacokinetics  in AnaesthesiologyPharmacokinetics  in Anaesthesiology
Pharmacokinetics in AnaesthesiologyKiran Rajagopal
 
Pharmacokinetics of drugs
Pharmacokinetics of drugsPharmacokinetics of drugs
Pharmacokinetics of drugskavya m
 

Similar to Drug Distribution & Factors Affecting Distribution (20)

3. Pharmacokinetics - I.ppt
3. Pharmacokinetics - I.ppt3. Pharmacokinetics - I.ppt
3. Pharmacokinetics - I.ppt
 
pharmacokinetics of injectable anesthetics  / dental implant courses by India...
pharmacokinetics of injectable anesthetics  / dental implant courses by India...pharmacokinetics of injectable anesthetics  / dental implant courses by India...
pharmacokinetics of injectable anesthetics  / dental implant courses by India...
 
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptx
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptxPharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptx
Pharmacokinetics of Drug_Pharmacology Course_Muhammad Kamal Hossain.pptx
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy ppt on pharmacokinetics pharmacolocy
ppt on pharmacokinetics pharmacolocy
 
Distribution.pptx
Distribution.pptxDistribution.pptx
Distribution.pptx
 
drug drugdistribut 1
drug drugdistribut 1drug drugdistribut 1
drug drugdistribut 1
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
 
05.1 drug distribution
05.1 drug distribution05.1 drug distribution
05.1 drug distribution
 
Pharmacokinetic
PharmacokineticPharmacokinetic
Pharmacokinetic
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Basics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptxBasics of Pharmacokinetic.pptx
Basics of Pharmacokinetic.pptx
 
Distribution edited
Distribution editedDistribution edited
Distribution edited
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharamcokinetics: Distribution
Pharamcokinetics: Distribution Pharamcokinetics: Distribution
Pharamcokinetics: Distribution
 
Pharmacokinetics in Anaesthesiology
Pharmacokinetics  in AnaesthesiologyPharmacokinetics  in Anaesthesiology
Pharmacokinetics in Anaesthesiology
 
DISTRIBUTION OF DRUG
DISTRIBUTION OF DRUGDISTRIBUTION OF DRUG
DISTRIBUTION OF DRUG
 
Pharmacokinetics of drugs
Pharmacokinetics of drugsPharmacokinetics of drugs
Pharmacokinetics of drugs
 

More from Vijay Kevlani

Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Vijay Kevlani
 
Pharmacology of Penicillin G
Pharmacology of Penicillin G Pharmacology of Penicillin G
Pharmacology of Penicillin G Vijay Kevlani
 
Introduction of Penicillin
Introduction of Penicillin Introduction of Penicillin
Introduction of Penicillin Vijay Kevlani
 
Pharmacology of Cephalosporins
Pharmacology of CephalosporinsPharmacology of Cephalosporins
Pharmacology of CephalosporinsVijay Kevlani
 
Histamine: Turnover, Release and Receptor
Histamine: Turnover, Release and Receptor   Histamine: Turnover, Release and Receptor
Histamine: Turnover, Release and Receptor Vijay Kevlani
 
Introduction to Drug Distribution
Introduction to Drug Distribution   Introduction to Drug Distribution
Introduction to Drug Distribution Vijay Kevlani
 
Autacoids: Introduction and classification
Autacoids: Introduction and classificationAutacoids: Introduction and classification
Autacoids: Introduction and classificationVijay Kevlani
 
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence  Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence Vijay Kevlani
 
Pharmacokinetics: Absorption (Transport mechanism)
Pharmacokinetics: Absorption (Transport mechanism)Pharmacokinetics: Absorption (Transport mechanism)
Pharmacokinetics: Absorption (Transport mechanism)Vijay Kevlani
 
Introduction to General pharmacology
Introduction to General pharmacologyIntroduction to General pharmacology
Introduction to General pharmacologyVijay Kevlani
 
Anatomy and Physiology: Brain Stem
Anatomy and Physiology: Brain StemAnatomy and Physiology: Brain Stem
Anatomy and Physiology: Brain StemVijay Kevlani
 
Osteoarthritis general
Osteoarthritis generalOsteoarthritis general
Osteoarthritis generalVijay Kevlani
 

More from Vijay Kevlani (20)

Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins
 
Pharmacology of Penicillin G
Pharmacology of Penicillin G Pharmacology of Penicillin G
Pharmacology of Penicillin G
 
Introduction of Penicillin
Introduction of Penicillin Introduction of Penicillin
Introduction of Penicillin
 
Pharmacology of Cephalosporins
Pharmacology of CephalosporinsPharmacology of Cephalosporins
Pharmacology of Cephalosporins
 
Histamine: Turnover, Release and Receptor
Histamine: Turnover, Release and Receptor   Histamine: Turnover, Release and Receptor
Histamine: Turnover, Release and Receptor
 
Introduction to Drug Distribution
Introduction to Drug Distribution   Introduction to Drug Distribution
Introduction to Drug Distribution
 
Autacoids: Introduction and classification
Autacoids: Introduction and classificationAutacoids: Introduction and classification
Autacoids: Introduction and classification
 
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence  Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence
Pharmacokinetics: Absorption & Bioavaibility & Bioequivalence
 
Pharmacokinetics: Absorption (Transport mechanism)
Pharmacokinetics: Absorption (Transport mechanism)Pharmacokinetics: Absorption (Transport mechanism)
Pharmacokinetics: Absorption (Transport mechanism)
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Cotrimoxazole
CotrimoxazoleCotrimoxazole
Cotrimoxazole
 
Introduction to General pharmacology
Introduction to General pharmacologyIntroduction to General pharmacology
Introduction to General pharmacology
 
Anatomy and Physiology: Brain Stem
Anatomy and Physiology: Brain StemAnatomy and Physiology: Brain Stem
Anatomy and Physiology: Brain Stem
 
Mid brain
Mid brainMid brain
Mid brain
 
Pons
PonsPons
Pons
 
Medulla Oblongata
Medulla OblongataMedulla Oblongata
Medulla Oblongata
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
CNS Disorders
CNS DisordersCNS Disorders
CNS Disorders
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Osteoarthritis general
Osteoarthritis generalOsteoarthritis general
Osteoarthritis general
 

Recently uploaded

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Recently uploaded (20)

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

Drug Distribution & Factors Affecting Distribution

  • 2. The delivery of a drug from the plasma to the interstitium primarily depends on • Blood flow • Capillary permeability • The degree of binding of the drug to plasma and tissue proteins and • The relative hydrophobicity of the drug. Drug distribution is the process by which a drug reversibly leaves the bloodstream and enters the interstitium (extracellular fluid) and/or the cells of the tissues.
  • 3. A. Blood flow The rate of blood flow to the tissue capillaries varies widely as a result of the unequal distribution of cardiac output to the various organs. Blood flow to the brain, liver, and kidney is greater than that to the skeletal muscles; adipose tissue has a still lower rate of blood flow.
  • 4. This differential blood flow partly explains the short duration of hypnosis produced by a bolus IV injection of thiopental. The high blood flow, together with the superior lipid solubility of thiopental, permit it to rapidly move into the CNS and produce anesthesia.
  • 5. Slower distribution to skeletal muscle and adipose tissue lowers the plasma concentration sufficiently so that the higher concentrations within the CNS decrease, and consciousness is regained
  • 6. B. Capillary permeability Capillary permeability is determined by capillary structure and by the chemical nature of the drug 1. Capillary structure: Capillary structure varies widely in terms of the fraction of the basement membrane that is exposed by slit junctions between endothelial cells cells
  • 7. In the brain, the capillary structure is continuous, and there are no slit junctions. This contrasts with the liver and spleen, where a large part of the basement membrane is exposed due to large, discontinuous capillaries through which large plasma proteins can pass. Blood-brain barrier: To enter the brain, drugs must pass through the endothelial cells of the capillaries of the CNS or be actively transported.
  • 8. For example, a specific transporter for the levodopa in the brain By contrast, lipid-soluble drugs readily penetrate into the CNS because they can dissolve in the membrane of the endothelial cells Ionized or polar drugs generally fail to enter the CNS because they are unable to pass through the endothelial cells of the CNS, which have no slit junctions
  • 9. 2. Drug structure: The chemical nature of a drug strongly influences its ability to cross cell membranes. Hydrophobic drugs, which have a uniform distribution of electrons and no net charge, readily move across most biologic membranes. These drugs can dissolve in the lipid membranes and, therefore, permeate the entire cell's surface.
  • 10. The major factor influencing the hydrophobic drug's distribution is the blood flow to the area By contrast, hydrophilic drugs, which have either a non-uniform distribution of electrons or a positive or negative charge, do not readily penetrate cell membranes, and therefore, must go through the slit junctions
  • 11. C. Binding of drugs to plasma proteins Reversible binding to plasma proteins sequesters drugs in a non diffusible form and slows their transfer out of the vascular compartment Binding is relatively nonselective as to chemical structure and takes place at sites on the protein to which endogenous compounds, such as bilirubin, normally normally attach
  • 12. Plasma albumin is the major drug-binding protein and may act as a drug reservoir; that is, as the concentration of the free drug decreases due to elimination by metabolism or excretion, the bound drug dissociates from the protein. This maintains the free-drug concentration as a constant fraction of the total drug in the plasma.
  • 13. Volume of Distribution The volume of distribution is a hypothetical volume of fluid into which a drug is dispersed. Although the volume of distribution has no physiologic or physical basis, it is sometimes useful to compare the distribution of a drug with the volumes of the water compartments in the body
  • 14.
  • 15.
  • 16. A. Water compartments in the body Once a drug enters the body, from whatever route of administration, it has the potential to distribute into any one of three functionally distinct compartments of body water or to become sequestered in a cellular site.
  • 17. 1. Plasma compartment: If a drug has a very large molecular weight or binds extensively to plasma proteins, it is too large to move out through the endothelial slit junctions of the capillaries and, thus, is effectively trapped within the plasma compartment.
  • 18. As a consequence, the drug distributes in a volume (the plasma) that is about six percent of the body weight or, in a 70-kg individual, about 4 L of body fluid. Heparin shows this type of distribution.
  • 19. 2. Extracellular fluid: If a drug has a low molecular weight but is hydrophilic, it can move through the endothelial slit junctions of the capillaries into the interstitial fluid. However, hydrophilic drugs cannot move across the lipid membranes of cells to enter the water phase inside the cell.
  • 20. Therefore, these drugs distribute into a volume that is the sum of the plasma water and the interstitial fluid, which together constitute the extracellular fluid. This is about twenty percent of the body weight, or about 14 L in a 70-kg individual. Aminoglycoside antibiotics show this type of distribution.
  • 21. Total body water: If a drug has a low molecular weight and is hydrophobic, not only can it move into the interstitium through the slit junctions, but it can also move through the cell membranes into the intracellular fluid. The drug, therefore, distributes into a volume of about sixty percent of body weight, or about 42 L in a 70-kg individual. Ethanol exhibits this apparent volume of distribution below).
  • 22. Other sites: In pregnancy, the fetus may take up drugs and thus increase the volume of distribution Drugs that are extremely lipid-soluble, such as thiopental, may also have unusually high volumes of distribution
  • 23. Apparent volume of distribution A drug rarely associates exclusively with only one of the water the water compartments of the body. Instead, the vast majority of drugs distribute into several compartments, often avidly binding cellular components for example, Lipid (abundant in adipocytes and cell membranes), proteins proteins (abundant in plasma and within cells), or nucleic acids (abundant in the nuclei of cells)
  • 24. Therefore, the volume into which drugs distribute is called the apparent volume of distribution, or Vd. Another useful way to think of this constant is as the partition coefficient of a drug between the plasma and the rest of the body
  • 25. Determination of Vd Distribution of drug in the absence of elimination: The apparent volume into which a drug distributes, Vd, is determined by injection of a standard dose of drug, which is initially contained entirely in the vascular system. The agent may then move from the plasma into the interstitium and into cells, causing the plasma concentration to decrease with time
  • 26. Assume for simplicity that the drug is not eliminated from the body; the drug then achieves a uniform concentration that is sustained with time The concentration within the vascular compartment is the total amount of drug administered, divided by the volume into which it distributes
  • 27. where C = the plasma concentration of the drug and D = the total amount of drug in the body. For example, if 25 mg of a drug (D = 25 mg) are administered and the plasma concentration is 1 mg/L, then Vd = 25 mg/1 mg/L = 25 L
  • 28. Distribution of drug when elimination is present: In reality, drugs are eliminated from the body, and a plot of plasma concentration versus time shows two phases.
  • 29. The initial decrease in plasma concentration is due to a rapid distribution phase in which the drug is transferred from the plasma into the interstitium and the intracellular water This is followed by a slower elimination phase during which the drug leaves the plasma compartment and is lost from the body for example, by renal or biliary excretion or by hepatic biotransformation
  • 30. The rate at which the drug is eliminated is usually proportional to the concentration of drug, C; that is, the rate for most drugs is first-order and shows a linear relationship with time if ln C (where lnC is the natural log of C, rather than C) is plotted versus time. This is because the elimination processes are not saturated
  • 31. Calculation of drug concentration if distribution is instant: Assume that the elimination process began at the time of injection and continued throughout the distribution phase Then, the concentration of drug in the plasma, C, can be extrapolated back to time zero (the time of injection) to determine C0, Which is the concentration of drug that would have been achieved if the distribution phase had occurred
  • 32. For example, if 10 mg of drug are injected into a patient and the plasma concentration is extrapolated to time zero, the concentration is C0 = 1 mg/L (from the graph shown), and then Vd = 10 mg/1 mg/L = 10 L.
  • 33. Uneven drug distribution between compartments: The apparent volume of distribution assumes that the drug distributes uniformly, in a single compartment. However, most drugs distribute unevenly, in several compartments, and the volume of distribution does not describe a real, physical volume, but rather, reflects the ratio of drug in the extra- plasmic spaces relative to the plasma space.
  • 34. Nonetheless, Vd is useful because It can be used to calculate the amount of drug needed to achieve a desired plasma concentration. For example, assume the arrhythmia of a cardiac patient is not well controlled due to inadequate plasma levels of digitalis. Suppose the concentration of the drug in the plasma is C1 and the desired level of digitalis (known from clinical studies) is a higher concentration, C2.
  • 35. The clinician needs to know how much additional drug should be administered to bring the circulating level of the drug from C1 to C2: (Vd)(C1) = Amount of drug initially in the body (Vd)(C2) = Amount of drug in the body needed to achieve the desire plasma concentration The difference between the two values is the additional dosage needed
  • 36. Effect of a large Vd on the half-life of a drug A large Vd has an important influence on the half-life of a drug, because drug elimination depends on the amount of drug delivered to the liver or kidney (or other organs where metabolism occurs) per unit of time
  • 37. Delivery of drug to the organs of elimination depends not only on blood flow, but also on the fraction of the drug in the plasma. If the Vd for a drug is large, most of the drug is in the extra plasmic space and is unavailable to the excretory organs. Therefore, any factor that increases the volume of distribution can lead to an increase in the half-life and extend the duration of action of the drug.
  • 38. Note: An exceptionally large Vd indicates considerable sequestration of the drug in some organ or compartment
  • 39. O